POLK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.12619999887076E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.82730000020115E-08 |
Normal-vs-Stage2 |
3.216400E-02 |
Normal-vs-Stage3 |
1.184040E-02 |
Normal-vs-Stage4 |
5.604100E-03 |
Stage1-vs-Stage2 |
3.486600E-01 |
Stage1-vs-Stage3 |
2.591200E-01 |
Stage1-vs-Stage4 |
5.834600E-01 |
Stage2-vs-Stage3 |
9.735000E-01 |
Stage2-vs-Stage4 |
8.832600E-01 |
Stage3-vs-Stage4 |
8.519400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.34220001358455E-09 |
Normal-vs-AfricanAmerican |
1.780680E-04 |
Normal-vs-Asian |
6.161600E-01 |
Caucasian-vs-AfricanAmerican |
4.415800E-01 |
Caucasian-vs-Asian |
2.573200E-01 |
AfricanAmerican-vs-Asian |
4.545800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.83799991787726E-10 |
Normal-vs-Female |
5.504200E-02 |
Male-vs-Female |
7.153100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.643700E-04 |
Normal-vs-Extreme_Weight |
4.6538000120222E-09 |
Normal-vs-Obese |
9.92600000000454E-05 |
Normal-vs-Extreme_Obese |
8.391900E-04 |
Normal_Weight-vs-Extreme_Weight |
2.667400E-01 |
Normal_Weight-vs-Obese |
6.438400E-01 |
Normal_Weight-vs-Extreme_Obese |
8.037000E-01 |
Extreme_Weight-vs-Obese |
6.561600E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.980000E-01 |
Obese-vs-Extreme_Obese |
5.642400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.214200E-04 |
Normal-vs-Age(41-60Yrs) |
9.88339999999921E-05 |
Normal-vs-Age(61-80Yrs) |
1.24129995171529E-09 |
Normal-vs-Age(81-100Yrs) |
1.201710E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.945000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.297400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.809600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.626090E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.175600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.914600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.89929968921854E-10 |
Normal-VS-Type2 PRCC |
6.036500E-04 |
Normal-VS-KIRP CIMP |
2.162800E-03 |
Normal-VS-Unclassified PRCC |
4.803600E-02 |
Type1 PRCC-VS-Type2 PRCC |
3.205600E-02 |
Type1 PRCC-VS-KIRP CIMP |
5.782800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
9.298400E-03 |
Type2 PRCC-VS-KIRP CIMP |
6.520800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.383600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.345200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.71039999996569E-06 |
Normal-vs-N1 |
2.709700E-02 |
Normal-vs-N2 |
4.822400E-03 |
N0-vs-N1 |
1.244790E-01 |
N0-vs-N2 |
8.528000E-01 |
N1-vs-N2 |
3.470400E-01 |
|
|